The commonly expressed idea that "man is as old as his arteries" reflects the widely accepted view that the state of the circulatory system plays a major role in the pathogenesis of human aging. Since many of the more prominent clinical features of old age are attributable to changes in the central nervous system, considerable attention has been directed in the last few years to the circulation and gross metabolism of the aged human brain. Most studies have indicated a decline in cerebral blood flow and metabolic rate, and a rise in cerebrovascular resistance with advancing age (Fazekas, Alman, and Bessman, 1952; Fazekas, Kleh, and Finnerty, 1955; Fazekas, Kleh, and Witkin, 1953 ; Scheinberg, Blackburn, Rich, and Saslaw, 1953; Schieve and Wilson, 1953) ; several have failed to confirm such age-dependent changes (Gordan, 1956 ; Shenkin, Novak, Goluboff, Soffe, and Bortin, 1953) ; and Shenkin and his coworkers have concluded that there are no significant alterations in cerebral circulation and metabolism in old age except in the presence of both hypertension and arteriosclerosis. I n a recent critical and comprehensive review of the subject, Kety (1956) has interpreted the available evidence as indicating rapid decreases in overall cerebral blood flow and oxygen consumption during childhood and adolescence, and more gradual but nonetheless progressive declines in these functions in the remaining lifespan.
Several pertinent questions appeared, however, to remain unanswered. In his review Kety (1956 ) attempted, as far as possible, to exclude from consideration all studies performed on patients with a diagnosis of hypertension, arterioclerosis, or senile psychosis. The remaining series were composed almost entirely of hospitalized patients; they included, therefore, a variety of diseases even if they were of a type deemed unlikely to alter cerebral circulation and metabolism. As he himself pointed out, studies on such patients represented only an approximation of the normal aging process." Furthermore, vascular disease such as arteriosclerosis, which is known to impair the cerebral circulation (Fazekas, Kleh, and Finnerty, 1955; Shenkin, Novak, Goluboff, Soffe, and Bortin, 1953; Schieve and Wilson, 1953) , is so frequently and often so subtly intertwined with the aging process that it is doubtful if it can be successfully excluded without the exercise of the most stringent criteria for its detection and rejection. There is little evidence to indicate that adequately rigorous measures to exclude less than clinically obvious arteriosclerosis were employed in any of the previously cited studies. The possibility remained, therefore, that their results reflected more the effects of vascular or other types of diseases commonly associated with aging rather than the effects of chronological or physiological age per se.
The objectives of the present study were several. First, it was hoped to ascertain clearly and conclusively whether reductions in cerebral blood flow and metabolic rate were inevitable accompaniments of the aging process and occurred in the absence of any detectable cardiovascular or other diseases so often present in the aged. In the event that such changes did indeed occur, evidence was sought which might indicate whether the primary defect was cerebral circulatory insufficiency with secondary neuronal damage and reduced cerebral metabolic rate or, contrariwise, primary neuronal or metabolic impairment followed by secondary diminution in blood flow in response to the reduced metabolic demand. Finally, in view of the rare opportunity afforded by the broad multidisciplinary nature of this project, possible correlates of cerebral circulatory and metabolic functions in the aged were sought in their clinical state, electroencephalographic patterns, cognitive, perceptual, and behavioral functions, psychiatric signs and symptoms, and sociological status and performance. The results of the latter investigations are reported elsewhere in this volume.
METHODS

Subject Material
I n order to isolate the effects of aging per se from those of other common age-associated variables on the cerebral circulatory and metabolic functions studied, a highly selected group of normal male subjects over 65 years of age were chosen for these investigations . A detailed description of the 60 group and the exact criteria for acceptance or rejection are presented in chapters 2 and 3. Two stages of selection were carried out, a careful preliminary screening in the field and then a thorough, rigorous series of examinations and evaluations after admission to the National Institutes of Health. Fiftyfour subjects met the criteria of the preliminary selection and were admitted for study.
Of these, only 27 fulfilled the exacting requirements of the second-stage evaluations for consideration as noninstitutionalized, normal elderly men as free of any apparent disease as possible, and functioning normally in their communities (group I). Twenty subjects were found to be suffering from minimal subclinical or asymptomatic diseases of various types, mainly vascular, and, therefore, did not meet the standards of group I. However, since their medical status was at least equal to and probably better than that of average men of similar age, they were included in the study as a separate group (group 11). Seven of the admitted subjects were found to be suffering from serious or advanced diseases which, it was felt, might themselves influence the results of the experimental studies; they were, therefore, excluded from either of the preceding groups (group 111).
Cerebral circulatory and metabolic studies were successfully accomplished in 26 of the 27 subjects in group I, 17 of the 20 subjects in group 11, and 4 of the 7 subjects in group 111. Except for mean arterial blood pressure, none of the data obtained in these studies played any part in the evaluation and classification of the subjects into their respective groups. The normal range of mean arterial blood pressure was defined as the mean value * three standard deviations (84223) obtained during similar cerebral circulatory and metabolic studies performed simultaneously on a group of 15 normal young subjects for the purpose of obtaining comparative data.
On the basis of this definition, 5 elderly subjects (Subjects Nos. 8, 18, 28, 33, and 3 5 ) , who fulfilled all the clinical requirements for inclusion in group I, were found to be hypertensive at the time of the cerebral blood flow determinations and were, therefore, relegated to group 11. In addition to the previously described groups of elderly men and normal young subjects, a series of 10 patients suffering from chronic brain syndrome with psychosis were admitted from St. Elizabeths Hospital (Washington, D.C.) and Spring Grove Hospital ( Catonsville, Md.) , and studied in a similar fashion in order to investigate further the relationship between this clinical condition and cerebral circulatory and metabolic functions.
Procedures
Cerebral blood flow (CBF) was determined by the nitrous oxide method as described by Kety and Schmidt (1948) , except that the measurement period was extended to 15 minutes to allow more time for equilibration between brain tissue and cerebral venous blood. Mean arterial blood pressure (MABP) was measured directly in the femoral artery by means of an airdamped mercury manometer adjusted to the level of the carotid artery; mean internal jugular venous blood pressure ( M JVP) was measured directly in the internal jugular vein by means of a Statham strain gauge (Model No. P23B) and Brush Universal Analyser (Model No. and oscillograph (Model No. .
Blood oxygen and carbon dioxide contents were determined by the manometric method of Van Slyke and Neill ( 1924) , but blood oxygen saturation was measured directly by the Triton X-100 spectrophotometric technique (Deibler, Holmes, Campbell, and Gans, 1959) . Blood pH was measured anaerobically at ambient temperature with a MacInnes-Belcher glass electrode and Cambridge potentiometer (Model R ) , and was then corrected to its value at 37" C by means of the factors of Rosenthal ( 1948) . The Nelson-Somogyi method (Nelson, 1944) was employed for the determination of blood glucose concentration, and arterial hemoglobin concentration was determined by conversion to cyanmethemoglobin and photometric measurement (Evelyn and Malloy, 1938) .
The following functions were computed from the directly measured variables described above. Cerebral oxygen consumption (CMRm) and glucose utilization ( CMRG) were calculated as the products of the CBF and the arteriovenous oxygen ([A-Vloz) and glucose ([A-V]a) differences, respectively. The Odglucose ratio ( 0~1~) was determined from the molar values of (A-V)Oz and (A-V)G, and the cerebral respiratory quotient (R.Q. ) was obtained by division of (A-V)oz into the cerebral arteriovenous carbon dioxide difference. Cerebral vascular resistance, the ratio of cerebral blood pressure gradient to blood flow, was calculated as the ratio of the MABP-M JVP difference to the CBF. Blood carbon dioxide tension (pCOz) was determined by means of the nomogram of Van Slyke and Sendroy (1928) , and the nomogram based on the data of Dill ( National Research Council, 1944) was employed for the determination of the internal jugular venous oxygen tension (PO&
Results
In tables la and lb are presented the individual data obtained in the normal elderly men (group I ) ; these include not only the values of the cerebral circulatory and metabolic functions but also of a variety of blood constituents known to influence these is a striking paucity of statistically significant differences between the two groups. Significant increases in both mean arterial blood pressure (MABP) and cerebral vascular resistance (CVR) were observed in the aged group, suggesting that vascular changes are so closely associated with aging that they cannot be avoided even by the stringent selection process employed in these studies. Similarly, the slight but significant decrease in arterial 0 2 saturation probably indicates some pulmonary changes with age. Cerebral blood flow (CBF) and oxygen consumption (CMRo2) in both groups were well within the ranges generally observed in normal young people (Sokoloff, 1960) , and although they were slightly lower in the elderly than in the young, the differences were far from being statistically significant. On the other hand, cerebral glucose utilization ( CMRG) in the aged was significantly reduced ( p , approximately 0.05), and in association with the discrepancy between the changes in CMRm and CMRc, the oxygen : glucose ratio ( 02m) was correspondingly though not significantly increased ; the possible implications of these findings will be discussed below. No other distinguishing features were observed. The results of the same studies in the elderly men with asymptomatic or subclinical disease (group 11) are summarized in tables 2a and 2b. Since the criteria for selection and classification relegated to this group all those subjects who were rejected from group I only because of an elevated blood pressure at the time of the cerebral flow studies, it is, of course, not surprising that the MABP of group I1 was markedly 64 higher than observed in either the young or normal elderly groups. In line with the generally observed relationship between arterial blood pressure and cerebral vascular resistance (Lassen, 1959) , CVR was also elevated, but the rise in CVR in this group was disproportionately greater than that of the MABP, resulting in a statistically significant 16-percent fall i n CBF below the level of the normal young subjects and a 10-percent decline, just short of statistical signifiance, below that of group I. CMRo2, however, was negligibly lower than that of group I and not significantly different from that of the normal young group. As might be expected from a fall in blood flow without a proportionate decrease in oxygen consumption, there were tendencies though not quite statistically significant, for the (A-V) o2 to widen and the internal jugular venous pOz, which probably reflects the 0 2 tension of the brain tissues, to fall. Cerebral glucose utilization ( CMRG) was similar to that of group I and significantly lower than that of the normal young subjects. I n all other respects, group I was similar to the normal elderly and normal young subjects.
Evidence of vascular disease was by far the most common cause of assignment of subjects to the group I1 category. In order to assess better the influence of such disease on the cerebral circulation and metabolism of the aged, subjects in group I1 so diagnosed were classified into several smaller but homogeneous subgroups based on the nature of their vascular disease. These sub- * Significantly different from normal young subjects at the 0.05 level .
course, manifested both conditions. These subgroups included 14 of the 17 subjects studied in group I1 ; in addition, one subject (No. 17), who had been rejected altogether because of moderately severe arteriosclerosis, was added for the purposes of this analysis to the normotensive arteriosclerotic subgroup. The results obtained in these individuals are presented in tables 3a and 3b, as well as the means and standard errors of the normal young subjects, normal elderly subjects, and the patients suffering from chronic brain syndrome, which are included for comparison. Despite the limited size of the subgroups, it is clear that it was the arteriosclerotic subjects who were chiefly responsible for the finding of a significant reduction in the CBF of group 11. Except for the expected higher values for MABP and CVR and a significant increase in the arteriovenous glucose difference, the results in the normal hypertensive subjects were essentially the same as in the normal young and normal elderly groups. On the other hand, the arteriosclerotic subjects, both hypertensive and normotensive, revealed significant, indeed considerable, reductions in CBF which could account for almost all of the decrease observed in group I1 as a whole (table 2a) . One of the normotensive arteriosclerotic subjects (No. 32) obviously hyperventilated at the time of the study, and it was probably his contribution which was mainly responsible for the significant reductions in the mean values for arterial p C 0~ and cerebral venous pOz observed in this subgroup; although in this one subject the hyperventilation undoubtedly contributed to cerebral vascoconstriction and reduced cerebral blood flow, it does not account for the low mean cerebral blood flow of the subgroup as a whole, which remains significantly reduced even when he is excluded from the data. Although there were no statistically significant changes in cerebral oxygen consumption and glucose utilization in the subgroups with vascular disease, CMRoz tended to be substantially lower in the arteriosclerotic subjects and might, perhaps, have been found to be significantly so had the series been larger. I n general, all the vascular disease subgroups tended to have increased arteriovenous oxygen and glucose differences, and the internal jugular venous pOz tended to fall progressively in going from the normal young group through the normal elderly and hypertensive groups, and finally, to the arteriosclerotic subjects.
In the patients with chronic brain syndrome and psychosis, there was unequivocal evidence of disturbances in both cerebral circulation and metabolism. Cerebral circulatory functions were essentially the same as in the arteriosclerotic subgroups of group 11, but there were in addition marked reductions in cerebral oxygen consumption and glucose utilization. Internal jugular venous ~O Z was statistically significantly below that of the normal young and normal elderly subjects, but the arteriovenous oxygen and glucose differences were similar to those of the normal subjects and considerably less than those of the subjects with vascular disease. The combination of a low CBF, low C M R O~, and normal (A-V)oz fails to distinguish between the possibilities of a reduced cerebral oxygen supply or a reduced cerebral oxygen demand in the pathogenesis of these changes; however, the additional finding of a low cerebral venous pOz suggests an anoxia of the cerebral tissues and a deficiency in supply relative to demand which in these patients was undoubtedly aggravated by a significant reduction in their arterial 0 2 saturation, presumably secondary to pulmonary dysfunction. that these were statistically insignificant
The possible nature of th&, deteriorative changes in series of rather appreciable size. of old age is suggested by the even if these changes could be results obtained in the group of elderly men construed to reflect something more than with asymptomatic or subclinical disease random variation, it would, in view of our (group 11). This group differed from the findings in the arteriosclerotic subjects, most normal elderly only in that they exhibited likely be the impossibility of completely rul-evidence of mild subclinical disease, gening out the variable of arteriosclerOsis from erally vascular, when subjected to an exacta presumably healthy aged ~o~u l a t i o n . ing clinical examination; yet in contrast to do not the normal elderly men, their CBF was sigrefute the previous evidence (KetY, lg56) nificantly reduced below that of the young that these functions usually decrease in the subjects. on further examination of the aged* The subjects Our group subgroups with vascular disease (table 3a) , Of normal men were it is clear that this reduction was not assoaccording to rigorous criteria and could ciated with hypertension, but could be achardly be considered representative of the counted for entirely by the findings in the aged PoPulation at large; were, as re-subjects with arteriosclerosis. In the subgards relative freedom from vascular and jects with hypertension alone, CBF and other diseases, far superior. Group 11, the CMRoz were like those of the normal young subjects with asymptomatic or subclinical and elderly subjects. O n the other hand, disease, were probably more representative in the arteriosclerotic patients, both normoof their age group, and, indeed, in this group tensive and hypertensive, CBF was signif-CBF was significantly reduced, and CMRoz icantly reduced by about 16-20 percent, tended to be lower though still not statisti-and CMRm also tended to be lower though cally significantly. The possibility may be not statistically significantly so in this small entertained that our normal old men in series. Furthermore, in all of the subjects group I may, because they were so select, with vascular disease there was a tendency have suffered declines in CBF and CMRo2 for the arteriovenous oxygen difference to from initially higher than average values increase and the internal jugular venous which could have been detected only by pOz to fall. The latter change was parlongitudinal studies. However, the basis of ticularly pronounced and statistically sigtheir selection was general freedom from nificant in the normotensive arteriosclerotic disease, and since there is no evidence to in-subjects; inasmuch as this function reflects To a peat extent, the almost 'peak for thern,dves.
were m e n t i d y the as in norma1 young cerebral tissue during adulthood is not a fulness.
On the Other hand, these measurements. O n the other hand, it is not inconceivable that there are with aging subtle changes in cerebral metabolism which result in a lowering of glucose utilization before a reduction in CMRoz becomes apparent. Normally there is slightly more glucose utilized by the brain than can be accounted for by the oxygen consumption, assuming complete oxidation of glucose (Kety, 1957; Sokoloff, 1960) . The fate of this excess glucose is at present uncertain. Himwich and Himwich ( 1946) have accounted for it by the cerebral pyruvate and lactate production, but others have failed to confirm this (Kety, 1957) . It is likely that some of this glucose and its derivatives are incorporated into the complex chemical constituents constantly being resynthesized by the brain (Geiger, 1958) . I n any case, there may be, in the aged, alterations in these aspects of cerebral carbohydrate metabolism which would not be reflected in cerebral oxygen consumption, but until there is confirmation of our findings and additional experimental evidence, further speculation would be unjustified.
As in most studies of this type, our data were obtained by means of the nitrous oxide method, and, therefore, apply only to a representative fraction of the brain as a whole rather than to the total brain. They are completely independent of changes in brain weight, but are more relevant to the events occurring within the tissues of the brain. The question of the total quantity of brain tissue or the amount of functioning tissue in the aged brain is an entirely different problem.
The absence of any significant changes in cerebral blood flow and oxygen consumption in the normal elderly men (group I )
should not be construed as evidence that there are no age changes in the central nervous system in the absence of disease. The fact that such changes do occur is 74 demonstrated by the findings of alterations in their cognitive and perceptual functions (chs. 8 and 9 ) and electroencephalographic activity (ch. 7). It suggests rather that these functions may be more sensitive indicators of the aging phenomenon in the brain or that they involve processes too subtle to be reflected in the gross blood flow and metabolic rate of the brain as a whole. O n the other hand, when vascular disease is present and leads to reductions in cerebral blood flow and oxygen tension, as it did in the arteriosclerotic patients, then it becomes the pacemaker of the aging process in the brain and results in more rapid deterioration of these other functions (chs. 7,8, and 9 ) . 4. The cerebral arteriovenous oxygen difference tended to be increased and the cerebral venous oxygen tension tended to fall in all the categories of vascular disease, particularly the arteriorsclerotic groups. These changes, though not quite statistically significant probably because of the small size of the individual categories, were pronounced and were, therefore, interpreted as evidence of relative cerebral circulatory insufficiency and hypoxia.
5. Although cerebral oxygen consumption was not decreased, there was a considerable and statistically significant fall in cerebral glucose utilization in the normal elderly subjects. The possible implications of this discrepancy between the two metabolic rates are discussed.
6. I n patients with chronic brain syndrome and psychosis, cerebral blood flow was markedly reduced, but no more so than in the arteriosclerotic subjects. However, in contrast to the arteriosclerotics, cerebral oxygen and glucose utilization was proportionately depressed so that the arteriovenous differences were within normal limits. Cerebral venous pOz remained low, however, indicating relative cerebral anoxia.
7. It is suggested that decreases in cerebral blood flow and oxygen consumption are not the consequences of chronological aging per se, but rather of arteriosclerosis which causes first a relative cerebral circulatory insufficiency and anoxia and then ultimately a secondary reduction in cerebral metabolic rate.
